Abstract
ABSTRACT: Synthetic pulmonary surfactants consisting of mixtures of phospholipids with synthetic peptides based on the amino acid sequence of human surfactant apoprotein SP-B were prepared. These surfactants were analyzed for their ability to lower surface tension on a pulsating bubble surfactometer and for their capacity to improve lung compliance and increase alveolar expansion in a fetal rabbit model of surfactant deficiency. The data demonstrate that several peptides, ranging from 17 to 45 residues in length, matching the carboxy-terminal sequence of the SP-B protein, when appropriately recombined with the phospholipids dipalmitoylphosphatidycholine and phosphatidylglycerol (3:1), are capable of producing a synthetic surfactant with biophysical and biologic activity approaching that of human surfactant derived from amniotic fluid.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Revak, S., Merritt, T., Hallman, M. et al. The Use of Synthetic Peptides in the Formation of Biophysically and Biologically Active Pulmonary Surfactants. Pediatr Res 29, 460–465 (1991). https://doi.org/10.1203/00006450-199105010-00010
Received:
Accepted:
Issue Date:
Further reading
-
Advances in synthetic lung surfactant protein technology
Expert Review of Respiratory Medicine (2019)
-
Effects of Amphipathic Polypeptides on Membrane Organization Inferred from Studies Using Bicellar Lipid Mixtures
Langmuir (2018)
-
Radiation Mitigating Properties of Intranasally Administered KL4Surfactant in a Murine Model of Radiation-Induced Lung Damage
Radiation Research (2017)
-
Peptide-based synthetic pulmonary surfactant for the treatment of respiratory distress disorders
Current Opinion in Chemical Biology (2016)
-
Delineation of the dynamic properties of individual lipid species in native and synthetic pulmonary surfactants
Biochimica et Biophysica Acta (BBA) - Biomembranes (2015)